MD (Pediatrix Medical Group) Equivalent Admissions #: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MD Pediatrix Medical Group Inc MD
50 GF Score
Price $26.08
GF Value $13.61
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Pediatrix Medical Group Equivalent Admissions #?

Pediatrix Medical Group MD -3.69% 50 Equivalent Admissions # is 0.00 as of . 20. GuruFocus rates MD with a GF Score™ of 50/100 and a GF Value™ of $13.61 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Pediatrix Medical Group's Equivalent Admissions # or its related term are showing as below:

MD's Equivalent Admissions # is not ranked *
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Pediatrix Medical Group Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for Pediatrix Medical Group's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pediatrix Medical Group Equivalent Admissions # Chart

Pediatrix Medical Group Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Equivalent Admissions #
Get a 7-Day Free Trial Premium Member Only Premium Member Only
No of Admissions #
Get a 7-Day Free Trial Premium Member Only Premium Member Only


MD vs ADUS, AVAH, SGRY: Equivalent Admissions # Comparison

For the Medical Care Facilities subindustry, Pediatrix Medical Group's Equivalent Admissions #, along with its competitors' market caps and Equivalent Admissions # data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MD
50GF Score
Pediatrix Medical Group Inc MD
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
Pediatrix Medical Group (MD) has a Equivalent Admissions # of 0.00 as of . 20. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pediatrix Medical Group and its competitors.
Is Pediatrix Medical Group's Equivalent Admissions # too high?
Pediatrix Medical Group's current Equivalent Admissions # is 0.00. Overall, Pediatrix Medical Group has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Equivalent Admissions # compare to ADUS and AVAH?
Pediatrix Medical Group's Equivalent Admissions # of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Healthcare Providers & Services company?
A good Equivalent Admissions # depends on the Healthcare Providers & Services industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Pediatrix Medical Group and its competitors. Pediatrix Medical Group's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (MD) is currently considered Significantly Overvalued. The stock's GF Value™ is $13.61, compared to a current price of $26.08 — trading 91.6% above its estimated fair value. The current Equivalent Admissions # is 0.00. Pediatrix Medical Group's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Pediatrix Medical Group (MD), the current Equivalent Admissions # is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pediatrix Medical Group (MD) Overvalued in 2026?

Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued. The current stock price of $26.08 is trading 91.6% above its estimated GF Value™ of $13.61. GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.

Key valuation signals for MD:

  • Equivalent Admissions #: 0.00
  • GF Value™: $13.61 vs. price of $26.08 (91.6% above fair value)
  • GF Score™: 50/100 with 8 warning signs

No single metric tells the full story. See the MD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pediatrix Medical Group Business Description

Other Exchanges PDC:Germany
Address 1301 Concord Terrace, Sunrise, FL, USA, 33323
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
50GF Score

Get the complete analysis for MD

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.08
Price
$13.61
GF Value